In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer. (2020)
Attributed to:
Mechanistic determination of how microRNAs control gene-expression
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202000770
PubMed Identifier: 33033111
Publication URI: http://europepmc.org/abstract/MED/33033111
Type: Journal Article/Review
Volume: 3
Parent Publication: Life science alliance
Issue: 12
ISSN: 2575-1077